Runchuan (Guangzhou) Commercial Development Co., Ltd. – Trademark Portfolio
Entity Type: 16
Runchuan (Guangzhou) Commercial Development Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include CELVÉE. The owner is based in Guangzhou City, Guangdong Province.
Rm 604, No. 163 Yuncheng South 2nd Road
Baiyun Dist.
Guangzhou City, Guangdong Province 510080 , CN
Showing of trademarks Trademarks
Trademark Classifications
Runchuan (Guangzhou) Commercial Development Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Runchuan (Guangzhou) Commercial Development Co., Ltd. have?
Runchuan (Guangzhou) Commercial Development Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does Runchuan (Guangzhou) Commercial Development Co., Ltd. file in?
Runchuan (Guangzhou) Commercial Development Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Runchuan (Guangzhou) Commercial Development Co., Ltd.'s most well-known trademarks?
Runchuan (Guangzhou) Commercial Development Co., Ltd.'s registered trademark portfolio includes well-known marks such as CELVÉE. These are among 1 currently registered trademark in the portfolio.
What is Runchuan (Guangzhou) Commercial Development Co., Ltd.'s trademark registration success rate?
Runchuan (Guangzhou) Commercial Development Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.